Secondary preventive medication persistence and adherence 1 year after stroke
- 20 September 2011
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology
- Vol. 77 (12), 1182-1190
- https://doi.org/10.1212/wnl.0b013e31822f0423
Abstract
Objective: Data on long-term use of secondary prevention medications following stroke are limited. The Adherence eValuation After Ischemic stroke–Longitudinal (AVAIL) Registry assessed patient, provider, and system-level factors influencing continuation of prevention medications for 1 year following stroke hospitalization discharge. Methods: Patients with ischemic stroke or TIA discharged from 106 hospitals participating in the American Heart Association Get With The Guidelines–Stroke program were surveyed to determine their use of warfarin, antiplatelet, antihypertensive, lipid-lowering, and diabetes medications from discharge to 12 months. Reasons for stopping medications were ascertained. Persistence was defined as continuation of all secondary preventive medications prescribed at hospital discharge, and adherence as continuation of prescribed medications except those stopped according to health care provider instructions. Results: Of the 2,880 patients enrolled in AVAIL, 88.4% (2,457 patients) completed 1-year interviews. Of these, 65.9% were regimen persistent and 86.6% were regimen adherent. Independent predictors of 1-year medication persistence included fewer medications prescribed at discharge, having an adequate income, having an appointment with a primary care provider, and greater understanding of why medications were prescribed and their side effects. Independent predictors of adherence were similar to those for persistence. Conclusions: Although up to one-third of stroke patients discontinued one or more secondary prevention medications within 1 year of hospital discharge, self-discontinuation of these medications is uncommon. Several potentially modifiable patient, provider, and system-level factors associated with persistence and adherence may be targets for future interventions.Keywords
This publication has 21 references indexed in Scilit:
- Antihypertensive Medication Adherence, Ambulatory Visits, and Risk of Stroke and DeathJournal of General Internal Medicine, 2010
- Persistent Use of Secondary Preventive Drugs Declines Rapidly During the First 2 Years After StrokeStroke, 2010
- Age and Persistent Use of Cardiovascular Medication After Acute Coronary Syndrome: Results from Medication Applied and Sustained Over TimeJournal of the American Geriatrics Society, 2009
- Medication Persistence Rates and Factors Associated with Persistence in Patients Following Stroke: A Cohort StudyBMC Neurology, 2008
- Medication Compliance and Persistence: Terminology and DefinitionsValue in Health, 2008
- Accuracy of Telephone Self-Report of Drug Use in Older People and Agreement with Pharmaceutical Claims DataDrugs & Aging, 2008
- Factors associated with medication refill adherence in cardiovascular-related diseasesJournal of General Internal Medicine, 2006
- Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic AttackStroke, 2006
- Adherence to MedicationThe New England Journal of Medicine, 2005
- EuroQol - a new facility for the measurement of health-related quality of lifeHealth Policy, 1990